DNA Copy Number Alterations in Radiation-induced Thyroid Cancer

Clinical Oncology

Volumn 23, Issue 4, 2011, Pages 289-296

  Zitzelsberger, H ^a   Unger, K ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Array CGH; CGH; Chernobyl; Genomic copy number; Thyroid cancer

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DATA ANALYSIS; DNA FRAGMENTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; THYROID CANCER;

ADULT; CHERNOBYL NUCLEAR ACCIDENT; CHILD; DNA, NEOPLASM; FEMALE; GENE DOSAGE; HUMANS; MALE; NEOPLASMS, RADIATION-INDUCED; NUCLEIC ACID HYBRIDIZATION; THYROID NEOPLASMS; UKRAINE;

EID: 79955039547     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2011.01.154     Document Type: Article

References (53)

1. Ron E., Lubin J.H., Shore R.E., et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995, 141:259-277.
2. Kazakov V.S., Demidchik E.P., Astakhova L.N. Thyroid cancer after Chernobyl. Nature 1992, 359:21.
3. Baverstock K., Egloff B., Pinchera A., Ruchti C., Williams D. Thyroid cancer after Chernobyl. Nature 1992, 359:21-22.
4. Cardis E., Howe G., Ron E., et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006, 26:127-140.
5. Jacob P., Bogdanova T.I., Buglova E., et al. Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiat Res 2006, 165:1-8.
6. Likhtarev I., Bouville A., Kovgan L., Luckyanov N., Voillequé P., Chepurny M. Questionnaire- and measurement-based individual thyroid doses in Ukraine resulting from the Chernobyl nuclear reactor accident. Radiat Res 2006, 166:271-286.
7. Williams G.H., Rooney S., Thomas G.A., Cummins G., Williams E.D. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer 1996, 74:585-589.
8. Nikiforov Y.E. RET/PTC rearrangement in thyroid tumors. Endocr Pathol 2002, 13:3-16.
9. Thomas G.A., Bunnell H., Cook H.A., et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 1999, 84:4232-4238.
10. Fugazzola L., Pilotti S., Pinchera A., et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 1995, 55:5617-5620.
11. Klugbauer S., Lengfelder E., Demidchik E.P., Rabes H.M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995, 11:2459-2467.
12. Tuttle R.M., Lukes Y., Onstad L., et al. ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout. Thyroid 2008, 18:839-846.
13. Unger K., Zitzelsberger H., Salvatore G., et al. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 2004, 89:4272-4279.
14. Unger K., Zurnadzhy L., Walch A., et al. RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. Br J Cancer 2006, 94:1472-1477.
15. Pinkel D., Segraves R., Sudar D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-211.
16. van Beers E.H., Joosse S.A., Ligtenberg M.J., et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer 2006, 94:333-337.
17. Buffart T.E., Tijssen M., Krugers T., et al. DNA quality assessment for array CGH by isothermal whole genome amplification. Cell Oncol 2007, 29:351-359.
18. Ergin B., Meding S., Langer R., et al. Proteomic analysis of PAXgene-fixed tissues. J Proteome Res 2010, 9:5188-5196.
19. Iafrate A.J., Feuk L., Rivera M.N., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
20. Sebat J., Lakshmi B., Troge J., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
21. Freeman J.L., Perry G.H., Feuk L., et al. Copy number variation: new insights in genome diversity. Genome Res 2006, 16:949-961.
22. Myers S.R., McCarroll S.A. New insights into the biological basis of genomic disorders. Nat Genet 2006, 38:1363-1364.
23. Khalique L., Ayhan A., Weale M.E., Jacobs I.J., Ramus S.J., Gayther S.A. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. J Pathol 2007, 211:286-295.
24. Liu Z., Li A., Schulz V., Chen M., Tuck D. MixHMM: inferring copy number variation and allelic imbalance using SNP arrays and tumor samples mixed with stromal cells. PLoS ONE 2010, 5. e10909.
25. Wang K., Li J., Li S., Bolund L., Wiuf C. Estimation of tumor heterogeneity using CGH array data. BMC Bioinformatics 2009, 10:12.
26. van de Wiel M.A., Kim K.I., Vosse S.J., van Wieringen W.N., Wilting S.M., Ylstra B. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 2007, 23:892-894.
27. Davies J.J., Wilson I.M., Lam W.L. Array CGH technologies and their applications to cancer genomes. Chromosome Res 2005, 13:237-248.
28. Coe B.P., Ylstra B., Carvalho B., Meijer G.A., Macaulay C., Lam W.L. Resolving the resolution of array CGH. Genomics 2007, 89:647-653.
29. Tuefferd M., De Bondt A., Van Den Wyngaert I., et al. Genome-wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays. Genes Chromosomes Cancer 2008, 47:957-964.
30. van de Wiel M.A., van Wieringen W.N. CGHregions: dimension reduction for array CGH data with minimal information loss. Cancer Inform 2007, 3:55-63.
31. Cremer C., Cremer T. Considerations on a laser-scanning-microscope with high resolution and depth of field. Microsc Acta 1978, 81:31-44.
32. Conchello J., Lichtman J.W. Optical sectioning microscopy. Nat Methods 2005, 2:920-931.
33. Cairns J.P., Chiang P.W., Ramamoorthy S., Kurnit D.M., Sidransky D. A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors. Clin Cancer Res 1998, 4:441-444.
34. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30. e57.
35. Kimmel R.R., Zhao L.P., Nguyen D., et al. Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat Res 2006, 166:519-531.
36. Rodrigues R.F., Roque L., Krug T., Leite V. Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines. Br J Cancer 2007, 96:1237-1245.
37. Richter H., Braselmann H., Hieber L., et al. Chromosomal imbalances in post-Chernobyl thyroid tumors. Thyroid 2004, 14:1061-1064.
38. Stein L., Rothschild J., Luce J., et al. Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from Chernobyl pediatric patients. Thyroid 2010, 20:475-487.
39. Unger K., Malisch E., Thomas G., et al. Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 2008, 27:4592-4602.
40. Finn S., Smyth P., O'Regan E., et al. Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines. Arch Pathol Lab Med 2007, 131:65-73.
41. Frau D.V., Lai M.L., Caria P., et al. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings. J Clin Endocrinol Metab 2008, 93:177-181.
42. Nakashima M., Takamura N., Namba H., et al. RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy. Hum Pathol 2007, 38:621-628.
43. Zitzelsberger H., Lehmann L., Hieber L., et al. Cytogenetic changes in radiation-induced tumors of the thyroid. Cancer Res 1999, 59:135-140.
44. Meyerson M., Gabriel S., Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010, 11:685-696.
45. Selzer R.R., Richmond T.A., Pofahl N.J., et al. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 2005, 44:305-319.
46. Hemmer S., Wasenius V.M., Knuutila S., Franssila K., Joensuu H. DNA copy number changes in thyroid carcinoma. Am J Pathol 1999, 154:1539-1547.
47. Mullenders L., Atkinson M., Paretzke H., Sabatier L., Bouffler S. Assessing cancer risks of low-dose radiation. Nat Rev Cancer 2009, 9:596-604.
48. Berg M., Agesen T.H., Thiis-Evensen E., et al. Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol Cancer 2010, 9:100.
49. Zhu Z., Gandhi M., Nikiforova M.N., Fischer A.H., Nikiforov Y.E. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 2003, 120:71-77.
50. Nikiforov Y.E. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008, 21(Suppl. 2):S37-S43.
51. Järvinen A., Autio R., Kilpinen S., et al. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 2008, 47:500-509.
52. van Wieringen W.N., van de Wiel M.A. Nonparametric testing for DNA copy number induced differential mRNA gene expression. Biometrics 2009, 65:19-29.
53. Rodrigues R., Roque L., Espadinha C., et al. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas. Oncol Rep 2007, 18:917-926.